Product Description
Brand Cepheid
Product Type PCR Kit
Pack Size 10T
CAT No XP3COV2/FLU/RSV-10
Application Molecular Biology
The Xpert Xpress CoV-2/Flu/RSV plus test is a multiplexed real-time PCR test intended for the simultaneous in vitro qualitative detection and differentiation of RNA from SARS-CoV-2, influenza A, influenza B, and/or RSV in nasopharyngeal swab or anterior nasal swab specimens collected from individuals with signs and/or symptoms of respiratory viral infection.
The Xpert Xpress CoV-2/Flu/RSV plus test:
- Provides fast and accurate results in as early as 25 minutes# for SARS-CoV-2.
- Utilizes a multi-gene target approach for the detection of SARS-CoV-2 and influenza providing target redundancy to mitigate the potential impact of genetic shift and drift on strain detection.
- Detects SARS-CoV-2, influenza A, influenza B, and/or RSV simultaneously.
Comprehensive, Multiplex Detection in a Single CartridgeThe Cepheid Xpert Xpress CoV-2/Flu/RSV plus allows simultaneous qualitative detection and differentiation of SARS-CoV-2, Influenza A, Influenza B, and RSV, all from a single patient specimen. This streamlines decision-making for clinicians and supports efficient patient management, particularly in respiratory infection seasons.
Fast Turnaround and Easy UsageWith a runtime of approximately 36 minutes from sample to result, the assay offers nearly immediate diagnostic feedback. The automated process, minimal sample preparation, and clear system-guided result output significantly reduce the manual burden on laboratory staff.
Flexible and Scalable Testing WorkflowsCompatible with GeneXpert platforms, test throughput ranges from single cartridges to 80+ tests per hour, enabling high-volume laboratories and smaller centers to scale testing based on current needs. Portable cartridge design allows for deployment in varying clinical environments.
FAQ's of Cepheid Xpert Xpress CoV-2/Flu/RSV plus:
Q: How does the Cepheid Xpert Xpress CoV-2/Flu/RSV plus test operate?
A: The test leverages real-time RT-PCR within a single-use cartridge, requiring only around 300 L of sample. Laboratories place the cartridge into a compatible GeneXpert system, which automates the entire process from nucleic acid extraction to result reporting.
Q: What types of samples are required for this assay?
A: The test accepts nasopharyngeal swabs, nasal swabs, or other respiratory specimens collected according to standard procedures recommended for respiratory virus testing.
Q: When should healthcare practitioners use this test?
A: This assay is intended for use when rapid and simultaneous detection of SARS-CoV-2, Influenza A, Influenza B, and RSV is clinically indicated, such as during symptomatic presentation, outbreaks, or respiratory infection seasons.
Q: Where can the Cepheid Xpert Xpress CoV-2/Flu/RSV plus be implemented?
A: The cartridge is designed for laboratory and clinical environments equipped with a GeneXpert or GeneXpert Infinity system, including hospital labs, reference laboratories, and diagnostic centers.
Q: What is the process for obtaining results from the test?
A: Collected samples are loaded into the cartridge, which is then inserted into the GeneXpert instrument. The fully automated run delivers qualitative results (Detected/Not Detected) for each virus in about 36 minutes, displayed via the system's software interface.
Q: What are the main benefits of using this assay?
A: Key advantages include rapid turnaround, high accuracy (>95%), multiplexing capability, minimal manual handling, and automated result interpretation, supporting both clinical effectiveness and workflow efficiency.
Q: How should the cartridges be stored and handled before use?
A: Store cartridges at 2-28C and avoid freezing. They should remain in their packaging until use, and always follow the manufacturer's shelf life and storage guidelines for optimal performance.